Primer: Glenmark Pharmaceuticals (GNP IN) - Aug 2026
Financial Turnaround and Growth Momentum: The company has demonstrated a significant financial turnaround, moving from a net loss in FY24 to...
96 Views
The GLP-1 Super-Cycle: Deconstructing India’s 2026 Patent Cliff and Alpha Generators
​Semaglutide patent expiration in India leads to 70% price drop, increasing access to affordable generic versions for obesity and diabetes treatment.
335 Views
APAC Healthcare Weekly (August 23) – Henlius Bio, Wuxi XDC, Chugai Pharma, Daiichi Sankyo, Celltrion
Henlius strikes biosimilar commercialization deal with Sandoz. Chugai signs exclusive license deal with GSK for anti-dengue virus antibody....
100 Views
Glenmark Pharmaceutical Ltd ~ Ambitious Guidance or Realistic Roadmap?
​Glenmark Pharmaceuticals is undergoing a strategic transformation into a science-led innovator, with a landmark partnership and plans for revenue...
277 Views
APAC Healthcare Weekly (August 2) – CSPC, Hengrui, Otsuka, Nippon Shinyaku, PharmaEssnetia, Cipla
Hengrui got NMPA approval for long-acting insulin. FDA approves Otsuka’s new CNS drug. Pharmaessentia announced positive topline result from Phase...
136 Views